Volume 8, Number 2—February 2002
Research
Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada
Table 2
Genomovar or species of Burkholderia cepacia complex or phenotypically similar isolates from cystic fibrosis patients in Canada
Species or genomovar | No. of patients infected with species or genomovara | Percentage of patients (%) |
---|---|---|
Genomovar I | 1 | 0.2 |
Burkholderia multivorans (genomovar II) | 43 | 9.3 |
Genomovar III | 369 | 80.0 |
Burkholderia stabilis (genomovar IV) | 17 | 3.8 |
Burkholderia vietnamiensis (genomovar V) | 7 | 1.6 |
Burkholderia cepacia complex (not genomovar I-VII) | 8 | 1.8 |
Burkholderia fungorum | 1 | 0.2 |
Burkholderia gladioli | 5 | 1.1 |
Ralstonia pickettii | 5 | 1.1 |
Pandoraea spp. |
5 |
1.1 |
Total | 461 |
aSome patients were counted twice if two or more different strains were recovered.
Page created: April 18, 2012
Page updated: April 18, 2012
Page reviewed: April 18, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.